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Summary: Aqueous solutions of cholesterol and some cholesteryl esters were prepared. The hydrolysis of cholesteryl
esters with enzymatic methods could therefore be studied in some detail.
The total cholesterol concentration of the aqueous cholesterol and cholesteryl ester solutions was determined by
6 different enzymatic procedures as well as the Liebermann-Burchard method.
For some esters (acetate and arachidonate esters) the esterase reaction is not complete within the usual reaction time,
whereas most other esters gave analytical results lower than the theoretical. With the Liebermann-Burchard method
all esters reacted completely within the reaction time.
The esterases have very different specificities for the various cholesteiyl esters.
With the enzymatic method several commercial control sera as well as human sera gave lower cholesterol concentrations
than the Liebermann-Burchard method. These differences can be explained mainly by this incomplete hydrolysis.
Some practical recommendations are given.
Unvollständige Hydrolyse von Cholesterinestern bei der enzymätischen Cholesterinbestimmung in wäßrigen Lösungen
von Cholesterinestern:
Vergleich von sechs enzymätischen Verfahren mit der Liebermann-Burchard-Methode
Zusammenfassung: Wäßrige Lösungen von Cholesterin und einigen Cholesterinestern wurden hergestellt; daran konnte
die Hydrolyse von Cholesterinestern mit enzymätischen Methoden in einigen Einzelheiten untersucht werden.
Die Cholesterin-Gesamtkonzentration der wäßrigen Cholesterin- und Cholesterinester-Lösungen wurde mit sechs ver-
schiedenen enzymätischen Verfahren sowie mit der Liebermann-Burchard-Meihode bestimmt.
Für einige Ester (Acetat-, Arachidonat-) ist die Esterasereaktion innerhalb der üblichen Reaktionszeit nicht vollständig,
während die meisten anderen Ester niedrigere Analysenresultate als theoretisch erwartet ergaben. Mit der Liebermann-
BurchardMeüaode reagieren die Ester innerhalb der Reaktionszeit vollständig.
Die Esterasen haben sehr unterschiedliche Spezifitäten für die verschiedenen Cholesterinester.
Mit der enzymätischen Methode ergaben mehrere käufliche Kontrollseren als auch Serum vom Menschen niedrigere
Cholesterinkonzentrationen als die Liebermann-Burchard-Methode. Diese Differenzen können im wesentlichen durch
unvollständige Hydrolyse erklärt werden.
Einige praktische Hinweise werden gegeben.
Introduction of total serum cholesterol were developed for the
clinical chemical laboratory (1-3). The methods were
With the availability of the enzymes cholesterol assumed to be more specific (4—8) than the Lieber-
esterase (EC 3.1.1.13) and cholesterol oxidase (EC mann-Burchard procedure (4,5, 9). Furthermore,
1.1.3.6), enzymatic methods for the determination the reaction conditions are considerably milder, as
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compared with the strong acidic medium of the
Liebermann-Burchard method. Moreover, the
enzymatic method can be used with various types
of instrument (7,8; 10-12).
The cholesterol concentrations obtained with the
enzymatic method are usually lower than those obtained
by the Liebermann-Burchard method (5, 7,11,13). This
was explained by the higher specificity of the enzymatic
methods. Yet interferences of the enzymatic procedures
by sterols (6, 14) and bilirubin (15) have been described.
Recently it was demonstrated that the enzymatic reac-
tions for the determination of cholesterol concentra-
tions proceed via more complicated pathways than was
previously expected (11,13,16-19).
Very recently Haeckel (11) assumed that-differences
between the analytical values of cholesterol determi-
nations from commercial control material might be a
result of the various esterase sources.
The esterase step was not studied. In addition, Deacon
(16) demonstrated different rates of hydrolysis of some
cholesteryl esters (in alcoholic solution) in the cholesterol
esterase catalyzed reaction.
For the Worthington and the Boehringer Mannheim
reagent kits, Chu found that longer times were required
for complete colour development with pure cholesteryl
ester solutions in /$0-propanol, than for the determina-
tion of cholesterol in human serum (17).
Very recently, during the National Meeting of the
American Association for Clinical Chemistry, Cooper
indicated that the enzymatic reactions are complex,
being accompanied by the formation of a number of
byproducts (13).
So far, the application of aqueous solutions of cholesteryl
esters in the determination of total cholesterol has
not been published, most probably due to the low
solubility of cholesterol and cholesteryl esters in
aqueous media.
In this paper, we describe the preparation of aqueous
solutions of cholesterol and some cholesteryl esters.
In all these solutions the total cholesterol concentra-
tions were determined, using 6 different enzymatic
methods and the Liebermann-Burchard method. The
results were compared with the theoretical concentra-
tions and gave us information about the rates of hydro-
lysis of the cholesteryl esters. All selected enzymatic
methods have the cholesterol esterase and cholesterol
oxidase catalyzed steps in common, but the subse-
quent indicator reactions are different. Furthermore,
four of these methods have, as far as we know, not
been described previously in the literature.
In addition, total cholesterol concentrations in some
commercial control sera and human sera were
determined. The results were compared, and could
for the greater part be explained by the results of the
experiments with the aqueous solutions of the
cholesteryl esters.
Materials and Methods
Reagents
Cholesterol, cholesteryl oleate, and cholesteryl steaiate were
from BDH Chemicals Ltd., England.
Cholesteryl palmitate, cholesteryl arachidonate, cholesteryl
linoleate, cholesteryl linolenate were from Sigma Chemical
Company Ltd., England.
Cholesteryl acetate, sodium azide, acetic acid, sulfuric acid,
acetic anhydride and sodium sulfate were from Merck AG.,
Germany.
Polyoxyethylene sorbitan monopalmitate (Tween-40) was
from Sigma Chemical Company Ltd., England.
Nordihydroguaiaretic acid was from Fluka AG., Switzerland.
All reagents were purchased in the purest available state.
Cholesterol and cholesteryl esters have a purity of 99% or
higher.
Preparation of an aqueous solution of cholesterol
(10.0 mmol/1)
This procedure was taken from Winckers & Jacobs (20).
To 50 ml of Tween-40 in a 250 ml flask was added 966.7 mg
of cholesterol and 25 mg of nordihydroguaiaretic acid. The
flask was heated in a boiling water bath until all the material
was dissolved. Then about 150 ml of a solution of sodium
azide in water (1 g/1) was added, and the mixture was heated
to 100 °C in a boiling water bath, until the solution was clear.
The solution was slowly cooled to room temperature. The
contents of the flask were then made up to 250 ml with the
sodium azide solution and thoroughly mixed; if necessary,
the volume was adjusted again.
Nordihydroguaiaretic acid (antiqxidant) and sodium azide
were added to increase the shelf life of the cholesterol
solution.
Preparation of aqueous solutions of cholesteryl esters
Aqueous solutions of cholesterol (5.0 mmol/1), cholesteryl ace-
tate (5.0 mmol/1), cholesteryl stearate (5.0 mmol/I), cholesteryl
palmitate (5.0 mmol/1), cholesteryl oleate (4.4 mmol/l), chole-
steryl linoleate (5.0 mmol/1), cholesteryl linolenate (5.0 mmol/1)
and chplesteryl arachidonate (5.2 mmol/l), were prepared accor-
ding to the procedure as described above for cholesterol (10.0
mmol/1).
In the same manner a blank was prepared omitting cholesterol
or cholesteryl esters.
All solutions are stable for at least two months at room tempera-
ture. At + 4 °C - + 8 °C, precipitation of cholesterol and
cholesteryl esters occurs.
Control sera
Autonorm (batch 210), Autonorm (batch 217), Seronorm (batch
130), and Seronorm Lipid (batch 54) were from Nyegaard & Co.
Norway.
Precilip (lot 764) and Precinorm U (lot 717) were from Boeh-
ringer Mannheim, Germany.
Armtrol (batch 475) was from Ross Ltd., England.
J. Clin. Chem. Clin. Biochem. / Vol. 18,1980 / No. 10
Incomplete hydrolysis of cholesteryl esters with cholesterol esterase 597
Hyland (lot NO4) from Travenol, Belgium.
Roche Lipid (lot S 2737) from Hoffmann-La Roche Ltd.,,
Switzerland.
Wellcomtrol (lot K 1989) from Wellcome, England.
The Roche enzymatic cholesterol test was carried out on a
Centrifichem 300 (Union Carbide). The Liebermann-Burchard
procedure was carried out on an Auto Analyzer II at a constant
temperature of 56 °C (40 samples per hour, the samples were
prediluted 1:2 with 9 g/1 NaCl-solution).
Analytical methods
For the enzymatic cholesterol determination the following
commercially available kits were used:
1. Test-Combination Cholesterol, CHOD-PAP method (phenol-
am inophenazone-peroxidase chromogen) from Boehringer
Mannheim. Germany
2. Cholesterol Test Roche, enzymatic (following the principle
first described by Harders & Helger, see I.e. (21) from Hoff-
mann-La Roche & Co. Ltd., Switzerland.
3. Dow Enzymatic Cholesterol Determination (phenol-am ino-
antipyrine-peroxidase chromogen) from Dow Chemical Co.,
USA.
4. System Cholesterol Enzymatic (following the principle first
described by Harders & Helger) from Merck AG., Germany.
5. Cholesterol Enzymatic (phenol-aminophenazone-peroxidase
chromogen) from Technicon, USA.
6. Cholesterol Oxidase Reagent Kit (phenol-aminoantipyrine-
peroxidase chromogen) from Baker Diagnostics, USA.
Unless otherwise indicated we followed the manufacturer's
instructions. The concentrations of the different components
in the working solution of these enzymatic methods are listed
in table 1.
For the Liebermann-Burchard procedure (22) we prepared the
following four liters of reaction mixture: a mixture of 2400 ml
of acetic anhydride p.a. and 1200 ml of acetic acid (glacial)
p.a. was cooled to -20 °C. To this mixture was added carefully
400 ml of cold (- 20 °C) sulfuric acid p.a. The temperature
rises to about + 25 °C. Finally, 80 g of sodium sulfate (an-
hydrous) p.a. was dissolved in the mixture.
Instruments
For the manual techniques we measured absorption on a
Beckman spectrophotometer, model 26. The Technicon
cholesterol enzymatic method was carried out on an Auto
Analyzer II (Technicon).
Standardization and performance
The prepared aqueous solution of cholesterol (10.0 mmoi/1)
was used as the standard for all methods. An aqueous solution
of cholesterol (5.0 mmol/1) was always taken as a control
material for all methods. The manual determinations were
performed in quadruplicate, whereas the experiments on the
Centrifichem and Auto Analyzer II were carried out in tri-
plicate. All methods give reproducible concentrations within
0.1 mmol/1.
Results
Linearity between absorbance and concentration of all
the kits was tested by using dilutions of the aqueous
cholesterol solution (10.0 mmol/1). In the range of
0.0—10.0 mmol/1, all methods showed a linear relation-
ship between absorbance and concentration. How-
ever, calibration curves of the Boehringer and Roche
methods demonstrated a small negative y-intercept.
In these cases the cholesterol concentrations were deter-
mined with the use of calibration curves. Since the
Merck test advices only 10 μΐ of sample we preferred
to use a Hamilton diluter for better precision of the
results. We recommend adjustment of the temperature
of reagents to that of the reaction, before they are
dispensed. The total cholesterol concentrations of
aqueous solutions of cholesteryl esters as determined
by the different methods are shown in table 2.
The enzymatic methods give lower cholesteryl ester
concentrations than does the Liebermann-Burchard
Tab. 1. Contents of the working solution of the different enzymatic cholesterol kits.
Constituents
Method
Merck Roche Boeh-
ringer
Baker Dow Technicon
Potassium phosphate
nHP"
Phenol
4-Aminophenazone
Potassium iodide
Ammonium molybdate
Alkylbenzyldimethylammonium-
chloride
Triton X-100
Cholesterol esterase
Cholesterol oxidase
Peroxidase
Sodium cholate
Sodium azide
Methanol
Hydroxypolyethoxydodecarie
Polyethyleneglycolmono[p-(l ,1 ,3,3,-
tetiamethylbutyl)phenyl]ether
Pegospcrse
(mol/1) 0.2
6.2
(mmol/1)
(mmol/1)
(mol/1) 0.12
(μιήοΐ/ΐ) 10
(g/D 0.1
(g/l)(U/l) 41
(U/l) 31
(U/l)
(mm l/1)
(mmol/1) 0.15
(mmol/1)
(%)
(g/D 2
(ml/l)
0.2
6.2
0.12
10
0.1
2
48
36
0.4
7.7
10
1
200
60
40
1850
0.2
7.0
34
1
85
165
17200
3
32
2 Λ.2
66
120
46000
1 ΠJLU
0.47 Λ
.2
6.6
2.6
93
131
1547
Ο ΟΛ830
cj
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Tab. 2. Analytical results (in mmol/1) of the cholesterol determination in aqueous solutions of cholesterol and some cholesteryl esters
(Standard solution: cholesterol 10.0 mmol/1).
Theore- Colori- Enzymatic determination
tical metry
concen- Lieber- Techni- Merck Boeh-
tration mann- con ringer
Burchard
Dow Roche1) Roche2) Baker
Fraction of
total
cholesterol
in serum3)
(mmol/1) (mmol/1) (mmol/1) (mmol/1) (mmol/1) (mmol/1) (mmol/1) (mmol/1) (mmol/1) (mmol/1)
Cholesterol
Cholesteryl acetate
Cholesteryl stearate
Cholesteryl palmitate
Cholesteryl oleate
Cholesteryl linoleate
Cholesteryl linolenate
Cholesteryl arachidonate
5.0
5.0
5.0
5.0
4.4
5.0
5.0
5.2
5.0
4.9
5.2
5.3
4.6
5.3
5.3
5.6
4.9
0.6
4.4
4.7
3.8
4.9
4.7
0.6
4.9
2.7
4.5
4.7
3.9
4.9
4.7
3.4
4.9
2.0
4.6
4.7
3.9
4.9
4.6
1.4
4.8
5.0
3.5
4.8
4.2
5.0
4.8
4.7
5.0
1.8
4.4
4.7
3.8
4.8
4.5
1.7
5.0
0.9
. 1.5
1.9
1.6
2.2
2.3
0.7
4.9
4.1
4.6
4.8
3.9
4.9
.4.5
3.0
0.30
0.00
0.02
0.07
0.15
0.35
0.03
0.04
*) Centrifichem, 24 min at 30 °C.
2) Centrifichem, 14 min at 25 °C.
3) See I.e. (16, 23-25).
procedure. The most significant result is that the
enzymatic methods gave even lower cholesterol con-
centrations than might be expected from the weighed
quantities. Especially low concentrations were measured
with the acetate and arachidonate esters. Only with the
Dow method, does the hydrolysis of the acetate and
arachidonate esters seem to be nearly complete, but
in this case the hydrolysis of the stearate ester was
incomplete.
It seems unlikely that Tween-40 may interfere with the
esterase reaction, because all enzymatic methods show
that hydrolysis of the linoleate ester is complete.
Additional support is obtained from the Dow Chemical
method, which, in contrast to the other methods, gives
complete hydrolysis of the acetate ester. Moreover,
hydrolysis of the other esters, with the exception of
cholesteryl stearate, is nearly'complete within the
reaction time.
Since the Roche test gave a Centrifichem procedure,
it was easy to measure the increase of the absorbance
with increasing reaction time for both the aqueous
cholesterol and the cholesteryl ester solutions. First the
manufacturer's instructions were carried out (14 min at
25 °C). The results are shown in table 2. The hydrolysis
is not complete, but the reaction with free cholesterol
is still not ended. Figure 1 shows that even at 30'°C none
of the reactions is complete within 14 minutes.
Only the curves of free cholesterol solutions and those
of the acetate, arachidonate, oleate and linoleate esters
were drawn. The curves of the other esters are found
between those of the linoleate and oleate esters. The
final absorbance of the free cholesterol solution (5.0
mmol/1) is less than half the absorbance of the free
cholesterol solution (10.0 mmol/1). This may suggest a
S 0.6 -
0.4 -
0.2 -
.[i
Si
12
Reaction
24
time [mini
Fig. 1. Variation of absorbance with time during the reaction of
cholesterol and some cholesteryl esters with the Roche kit.
A: Cholesterol (10.0 mmol/1).
B: Cholesterol (5.0 mmol/1).
C: Cholesteryl linoleate (5.0 mmol/1).
D: Cholesteryl oleate (4.4 mmol/1).
E: Cholesteryl acetate (5.0 mmol/l).
F: Cholesteryl arachidonate (5.2 mmol/1).
nonlinear assay even for free cholesterol, but it results
from a small negative y-intercept of the calibration curve.
This figure clearly shows that the initial reaction rate
of the free cholesterol solution (5 .0 mmol/1) is greater
J. Clin. Chem. Clin. Biochem. / Vol. 18, 1980 / No. 10
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Tab. 3. Concentrations of total cholesterol (mmol/1) in
10.0 mmol/1).
Cholesterol (5 mmol/1)
Autonorm 210
Autonorm 217
Armtrol 475
Hyland
Precilip
Precinorm U
Roche Lipid
Seronorm 130
Seronorm Lipid
Wellcomtrol
Colori-
metry
Lieber-
mann-
Burchard
(mmol/1)
5.0
3.8
6.2
4.4
3.6
4.3
3.9
9.3
2.7
7.1
4.9
several control sera (Standard solution: cholesterol
Enzymatic determination
Techni-
con
(mmol/1)
4.9
3.2
5.0
3.8
3.1
3.6
3.3
7.8
2.4
6.3
3.4
Merck
(mmol/1)
4.9
2.8
4.7
3.3
2.9
3.4
3.2
7.3
1.8
6.0
3.5
Boeh-
ringer
(mmol/l)
4.9
3.9
5.7
1
 4.5
3.7
4.3
4.1
8.7
2.9
7.2
4.3
Dow
Chemical
(mmol/1)
4.8
3.6
5.8
—3.2
3.8
3.6
9.4
2.3
7.2
4.6
Roche1)
(mmol/1)
5.0
2.7
4.4
—2.8
3.2
3.1
7.2
1.9
5.8
3.3
Baker
(mmol/1)
4.9
3.7
5.7
3.4
4.0
3.7
8.2
2.7
7.0
4.3
1 ) Centriflchem, 24 min at 30 °C.
than those of the eholesteryl esters. Moreover, the
oleate, acetate, and arachidonate esters have remark-
ably lower absorbances than were expected from the
theoretical total cholesterol concentrations. Even after
36 min at 30 °C the hydrolysis of cholesteryl arachi-
donate is not complete.
Furthermore, with long reaction times the absorbance
of the reaction mixture decreased. On account of the
above findings an incubation time of 24 min at 30 °C
was chosen. The results are given in table 2. Similar
results were found with an incubation time of 16 min
at 37 °C.
Determination of total cholesterol concentration in a
number of commercial control sera was performed with
all methods mentioned. In order to cancel put some
variables, the experiments with the control sera were
carried out on the same day. Moreover, for all the
methods of cholesterol determination, the same vial of
a particular control serum was used. The results are given
in table 3. From table 3, it can be seen that the tests
of Baker and Boehringer give equal or .somewhat lower
concentrations than the Liebermann-Burchard technique.
The tests of Technicon, Merck, and Roche show con-
siderably lower values than those obtained with the
Liebermann-Burchard procedure. The Merck and Roche
methods on their turn, give somewhat lower results than
the Technicon method.
We emphasize that the colour development of the
chromogen systems is faster in the control sera (and
in human sera,) than in the case of the aqueous solutions
of cholesterol. As already mentioned the colour develop-
ment in the Roche test for free cholesterol is complete
after 24 min at 30 °C. For the .control sera, the colour
development is already complete after 14 min at 25 °C,
and is thus within the manufacturer's reaction time.
In addition, cholesterol concentrations were determined
in a number of patient sera (tab. 4). Some of these sera
were expected to contain rather high cholesterol levels.
The values obtained with most enzymatic methods are
lower than those observed with the Liebermann-Burchard
method. The Baker and Boehringer tests gave nearly the
same results as the Liebermann-Burchard method.
The Dow test gave somewhat lower results than the
Liebermann-Burchard method, but still higher than those
obtained by the Merck, Technicon and Roche tests.
Tab. 4. Cholesterol concentrations (mmol/1) in a number of
patient sera (Standard solution: cholesterol 10.0 mmol/1).
Colori- Enzymatic determination
metry
Patient Lieber- Boeh- Techni- Merck
mann- ringer con
Burchard
(mmol/1) (mmol/1) (mmol/1) (mmol/1)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
8.0
6.6
4.8
7.5
6.2
7.5
5.6
7.0
6.4
9.0
5.5
7.8
7.3
6.8
6.7
6.2
6.0
7.9
6.4
4.9
7.5
6.1
7.4
5.8
7.0
6.5
9.0
Dow
(mmol/1)
5.0
7.6
6.9
6.4
6.4
5.9
5.4
7.3
5.9
4.4
7.0
5.7
7.0
5.3
6.5
5.9
8.4
Baker
(mmol/i)
5.3
7.8
7.3
6.8
6.5
6.2
5.8
7.1
5.7
4.0
6.9
5.5
6.8
5.2
6.4
6.0
8.5
Roche
(mmol/1)
4.4
7.4
6.6
6.0
6.0
5.6
5.1
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The last column of table 2 shows the normal distribu-
tion of cholesterol and cholesteryl esters in serum.
A mixture of cholesterol and cholesteryl esters of
7.0 mmol/1 was made containing the same distribution.
All the methods were used to determine the total
cholesterol concentration in this mixture. The results
are shown in table 5 a. In the second column we show
the recovery of the analytical value with respect to
the theoretical concentration.
A theoretical recovery can also be calculated from the
normal distribution of cholesterol and cholesteryl esters
and the results from table 2. For each separate ester
the recovery of the analytical concentration with respect
to the weighed value can be determined from table 2.
This recovery has been multiplied by the relative con-
tent of that particular ester in a normal serum. This
result gives the contribution of the recovery of that
ester to the total recovery. The theoretical recovery is
equal to the sum of these contributions. The values are
shown in the third column of table 5 a. It can be seen
that the analytical recovery is in excellent agreement
Tab. 5. Determination and recovery of the total cholesterol
concentration in an aqueous solution of a natural
mixture of cholesterol and cholesteryl esters, and correc-
tion for incomplete hydrolysis of the cholesteryl esters.
a) Determination and recovery of the total cholesterol
concentration in an aqueous solution of a mixture of
cholesterol and cholesteryl esters corresponding to a
normal distribution in native sera.
(Total cholesterol concentration is 7.0 mmol/1).
Method Analytical Analytical Theoretical
concentra- recovery recovery
tion
(mmol/1) (%) (%)
Lieb ermann-Bur chard 7.2
Technicon (enzymatic) 6.4
Merck 6.6
Boeh ringer 6.5
Dow Chemical 6.8
Roche 6.5
Baker 6.7
103
91
94
93
97
93
96
103.8
92.8
95.0
93.6
97.9
92.9
95.2
b) Determination of the total cholesterol concentra-
tion in a native serum corrected to obtain 100%
recovery.
Method
.
Lieb ermann-Bur 'chard
Technicon (enzymatic)
Merck
Boehringer
Dow Chemical
Roche
Baker
Analytical
concentra-
tion
(mmol/1)
7.2
6.5
6.8
7.2
6.9
6.6
7.1
Corrected
concentra-
tion from
analytical
recovery
(mmol/1)
7.0
7.1
7.2
7.7
7.1
7.1
7.4
Corrected
concentra-
tion from
theoretical
, recovery
(mmol/lj
7.0
7.0
74
7.7
7.0
7.1
7.4
with the theoretical one. For all these methods we
applied a correction of the cholesterol concentrations
found in human serum (tab. 5b) by multiplication of
the analytical cholesterol concentrations by 100,
divided by the recovery (in %).
The example in table 5b indicates that, with the excep-
tion of Bpehringer's method, comparable results are
obtained. The other human sera behave in the same
manner.
Bilirubin concentrations were also determined, but no
correction of cholesterol concentrations was necessary.
Discussion
By preparing aqueous solutions of cholesterol and
cholesteryl esters, it was possible to obtain information
about the hydrolysis of the esters in the esterase step.
Table 2 shows that with the enzymatic methods rela-
tively low total cholesterol concentrations were obtained
for the ester solutions. However, for all methods the
cholesterol concentration for the free cholesterol solu-
tion (5.0 rnmol/1) is equal to the theoretical one. It
indicates that the reaction with cholesterol oxidase is
complete within the reaction time. Therefore we assume
that the differences between the analytical values of the
various cholesteryl esters are ä result of different rates
of hydrolysis of the cholesterol esterase step. This con-
clusion is in agreement with recent results of Deacon
&Dawson (16), but in our case the relative rates of the
enzymatic hydrolysis of the esters vary strongly with
those found by these authors. Those differences may
be a result of the great differences in the reaction media.
Deacon &Dawson used propan-2-ol as the solvent,
whereas we dissolved the esters in an aqueous medium.
Since the relatively low concentrations can be ex-
plained by the degree of hydrolysis in the esterase
step, the assumed specificity of the enzymatic methods
becomes more or less doubtful. The commercial control
sera (see tab. 3) exhibit additional effects, because con-
siderably larger differences in cholesterol concentrations
were obtained between the enzymatic methods and the
Liebennann-Burchard procedure, than might be expected
from the results from table 2. An explanation could be
that some control sera might contain relatively high
concentrations of cholesteryl acetate and/or cholesteryl
arachidonate, but in our opinion a more probable expla-
nation is that in the commercial sera, the esterase step
of some kits is partly inhibited (especially the Technicon,
Merck, and Roche tests).
The Dow and Baker tests indicated higher cholesterol
concentrations in the control sera than were found by
the kits of Merck, Technicon and Roche. Most prob-
ably this is a result of better hydrolysis at the esterase
j. Clin. Chem. Clin. Biochem. / Vol. 18,1980 / No. 10
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step (see tab. 2). However, the Boehringer kit gave
higher values than were expected from the results in
table 2. The reactions of control sera and of free
cholesterol with the Boehringer kit showed no further
increase in absorbance after longer reaction times.
Unfortunately these experiments gave no satisfactory
explanation for the relatively high analytical values of
the Boehringer kit.
The differences between the total cholesterol concen-
trations in 27 human sera, as determined by all methods,
are smaller than were obtained with the commercial
control sera (see tab. 4). This is most probably a
result of the above mentioned additional effects
which occur in commercial sera.
In table 2 we also gave the mean distribution of
cholesterol and some of its esters in a normal serum.
These values were taken from the mean of the distri-
butions as described in I.e. (16, 23—25).
The differences between the analytical values of the
enzymatic methods and the Liebermann-Burchard
method can for the greater part be explained (see
Results).
Theoretically the enzymatic cholesterol determination
should have higher specificity than the "chemical"
Liebermann-Burchard method. Practically, however,
as demonstrated in this paper, the enzymatic methods
are more complicated than previously was expected
because of the different concentrations of cholesteryl
esters in native sera.
If commercial sera are used for standardization, large
differences in the cholesterol concentrations may be
expected for the various enzymatic methods. These
differences can be reduced considerably if aqueous
solutions of cholesterol are used.
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